April 26, 2018
ASA: Anesthesia drug shortages affecting patient care
Editor's Note
The American Society of Anesthesiologists (ASA) on April 25 reported that a national drug shortage of injectable opioids and local anesthetics is negatively affecting care received by patients under anesthesia.
An informal survey of 2,500 ASA members, found that 98% are now experiencing drug shortages at their institutions, and more than 95% say the shortages are affecting the way they treat their patients.
The top five drugs in short supply are hydromorphone, fentanyl, morphine, bupivacaine, and epinephrine.
Free Daily News
- Study: Education, exercise improve knee OA with or without prior surgery
- Study: Early surgery outperforms endoscopy for long-term pancreatitis
- Study: Blood thinner, NSAID combination raises bleeding risk
- Hospital financial report predicts stability, high cybersecurity costs for 2025
- IV fluid shortage drives innovation in hospital hydration practices
- FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators
- Five leadership lessons from an ASC CEO
- CMS final rule for CY 2025: Key updates impacting Medicare payments, quality programs
- GAO urges HHS to strengthen cybersecurity oversight
- Study: GLP-1s reduce TKA complications for non-diabetic patients with obesity
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement